Psoriatic Arthritis

Latest News

Assessing the Accuracy of Questionnaire-Based Screening Tools for Detection of Psoriatic Arthritis

Assessing the Accuracy of Questionnaire-Based Screening Tools for Detection of Psoriatic Arthritis

Researchers reviewed the accuracy and characteristics of questionnaire-based PsA screening tools.

Filgotinib Effective for Treatment of Active Psoriatic Arthritis

Filgotinib Effective for Treatment of Active Psoriatic Arthritis

Data show that filgotinib is effective for the treatment of active psoriatic arthritis.

Gout Associated With Psoriatic Arthritis, Psoriasis in Adults

Gout Associated With Psoriatic Arthritis, Psoriasis in Adults

Data show an increased prevalence of psoriasis in patients with gout compared with patients without gout.

Influenza Vaccination Low in Rheumatoid Arthritis, Psoriatic Arthritis

Influenza Vaccination Low in Rheumatoid Arthritis, Psoriatic Arthritis

Patients with rheumatoid arthritis or psoriatic arthritis have a low influenza vaccination rate, despite the recommendation from the CDC to be vaccinated annually.

Statins May Decrease C-Reactive Protein Levels in Psoriatic Arthritis

Statins May Decrease C-Reactive Protein Levels in Psoriatic Arthritis

Statin therapy was associated lower CRP levels in psoriatic arthritis treated with statins, possibly indicating decreased systemic inflammation.

No Significant Risk for Atrial Fibrillation, CV Events in PsA Receiving Ustekinumab vs TNF Inhibitors

No Significant Risk for Atrial Fibrillation, CV Events in PsA Receiving Ustekinumab vs TNF Inhibitors

The primary and secondary outcomes included incident AF or a composite CV event that included myocardial infarction, stroke, and coronary revascularization.

Ustekinumab and Secukinumab Safe, Efficacious for Psoriatic Arthritis

Ustekinumab and Secukinumab Safe, Efficacious for Psoriatic Arthritis

Among a new line of biological and targeted synthetic DMARD, ustekinumab and secukinumab have shown favorable safety and efficacy profiles for psoriasis and arthritis, respectively in patients with psoriatic arthritis.

Greater Entheseal Damage, Inflammation Observed in Psoriatic Arthritis vs Ankylosing Spondylitis

Greater Entheseal Damage, Inflammation Observed in Psoriatic Arthritis vs Ankylosing Spondylitis

Patients with psoriatic arthritis had greater entheseal insertion damage scores compared with patients with ankylosing spondylitis.

Radiographic Changes in PsA: Conventional Synthetic DMARDs vs Anti-TNF Therapy

Radiographic Changes in PsA: Conventional Synthetic DMARDs vs Anti-TNF Therapy

Investigators assessed radiographic progression in patients with psoriatic arthritis following transition from conventional synthetic disease-modifying rheumatic drugs to anti-tumor necrosis factor-α therapy.

Use of DAPSA28 for Assessment of Disease Activity in Psoriatic Arthritis

Use of DAPSA28 for Assessment of Disease Activity in Psoriatic Arthritis

Investigators sought to determine the validity of using a simplified scoring tool that assesses 28 joint counts compared with the original 66/68 joint counts in patients with psoriatic arthritis.

Sign Up for Free e-newsletters